270 related articles for article (PubMed ID: 22672067)
21. The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic.
Roberts KK; Cochet AE; Lamb PB; Brown PJ; Battafarano DF; Brunt EM; Harrison SA
Aliment Pharmacol Ther; 2015 Feb; 41(3):293-300. PubMed ID: 25521607
[TBL] [Abstract][Full Text] [Related]
22. Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.
Vongsuvanh R; George J; McLeod D; van der Poorten D
J Hepatol; 2012 Aug; 57(2):392-8. PubMed ID: 22521350
[TBL] [Abstract][Full Text] [Related]
23. Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.
Uchil D; Pipalia D; Chawla M; Patel R; Maniar S; Narayani ; Juneja A
J Assoc Physicians India; 2009 Mar; 57():201-4. PubMed ID: 19588647
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
Coulon S; Francque S; Colle I; Verrijken A; Blomme B; Heindryckx F; De Munter S; Prawitt J; Caron S; Staels B; Van Vlierberghe H; Van Gaal L; Geerts A
Cytokine; 2012 Aug; 59(2):442-9. PubMed ID: 22658783
[TBL] [Abstract][Full Text] [Related]
26. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
Gisondi P; Tessari G; Conti A; Piaserico S; Schianchi S; Peserico A; Giannetti A; Girolomoni G
Br J Dermatol; 2007 Jul; 157(1):68-73. PubMed ID: 17553036
[TBL] [Abstract][Full Text] [Related]
28. Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD.
Boursier J; Chaigneau J; Roullier V; Lainé F; Sandrini J; Michalak S; Hubert I; Dib N; Oberti F; Bertrais S; Hunault G; Deugnier Y; Rousselet MC; Cavaro-Ménard C; Gallois Y; Aubé C; Calès P;
Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):974-81. PubMed ID: 21904208
[TBL] [Abstract][Full Text] [Related]
29. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
30. Hepatic histology in obese patients undergoing bariatric surgery.
Machado M; Marques-Vidal P; Cortez-Pinto H
J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
[TBL] [Abstract][Full Text] [Related]
31. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
32. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease.
Abedini R; Salehi M; Lajevardi V; Beygi S
Clin Exp Dermatol; 2015 Oct; 40(7):722-7. PubMed ID: 25958919
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of non-alcoholic fatty liver disease.
Bellentani S; Scaglioni F; Marino M; Bedogni G
Dig Dis; 2010; 28(1):155-61. PubMed ID: 20460905
[TBL] [Abstract][Full Text] [Related]
34. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
Abrams GA; Kunde SS; Lazenby AJ; Clements RH
Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
[TBL] [Abstract][Full Text] [Related]
35. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.
Targher G; Bertolini L; Padovani R; Poli F; Scala L; Tessari R; Zenari L; Falezza G
Diabet Med; 2006 Apr; 23(4):403-9. PubMed ID: 16620269
[TBL] [Abstract][Full Text] [Related]
36. Non-alcoholic steatohepatitis in type 2 diabetes mellitus.
Gupte P; Amarapurkar D; Agal S; Baijal R; Kulshrestha P; Pramanik S; Patel N; Madan A; Amarapurkar A; Hafeezunnisa
J Gastroenterol Hepatol; 2004 Aug; 19(8):854-8. PubMed ID: 15242486
[TBL] [Abstract][Full Text] [Related]
37. Association of nonalcoholic fatty liver disease with metabolic syndrome in Indian population.
Sanal MG; Sarin SK
Diabetes Metab Syndr; 2011; 5(2):76-80. PubMed ID: 22813407
[TBL] [Abstract][Full Text] [Related]
38. A case-control study on nutritional risk factors in non-alcoholic fatty liver disease in Indian population.
Sathiaraj E; Chutke M; Reddy MY; Pratap N; Rao PN; Reddy DN; Raghunath M
Eur J Clin Nutr; 2011 Apr; 65(4):533-7. PubMed ID: 21346716
[TBL] [Abstract][Full Text] [Related]
39. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
Candia R; Ruiz A; Torres-Robles R; Chávez-Tapia N; Méndez-Sánchez N; Arrese M
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):656-62. PubMed ID: 25418531
[TBL] [Abstract][Full Text] [Related]
40. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
Hsiao PJ; Kuo KK; Shin SJ; Yang YH; Lin WY; Yang JF; Chiu CC; Chuang WL; Tsai TR; Yu ML
J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
